Dr. Hornick received a BA from Amherst College and an MD/PhD from the University of Southern California. He trained as a resident in Anatomic Pathology and pursued subspecialty fellowships in soft tissue pathology and gastrointestinal pathology at Brigham and Women’s Hospital, where he is the Director of Surgical Pathology and Immunohistochemistry and Chief of Soft Tissue and Bone Pathology. Dr. Hornick is a Professor of Pathology at Harvard Medical School, the Mass General Brigham Endowed Cancer Chair, and a consultant at the Dana-Farber Cancer Institute.

Dr. Hornick is Past-President of the Arthur Purdy Stout Society and previously chaired the USCAP Education Committee, the USCAP Abstract Review Board and Assignment Committee, and the CAP Immunohistochemistry Committee. He served as Co-Director of the Diagnostic Pathology Update course; Coordinator for Soft Tissue Pathology Interactive Microscopy courses; and Moderator of the Bone and Soft Tissue Specialty Conference, the Surgical Pathology Specialty Conference, and platform sessions on Bone and Soft Tissue Pathology and Gastrointestinal Pathology for the USCAP. Dr. Hornick currently serves on the NCCN Bone Cancer Panel and the CAP Personalized Health Care Committee. He was a member of the expert editorial board for the 4th (2013), 5th (2020), and 6th (2025) editions of the WHO Classification of Tumors of Soft Tissue and Bone. Dr. Hornick served on the Anatomic Pathology Test Development and Advisory Committee for the American Board of Pathology, the Soft Tissue Sarcoma Expert Panel for the AJCC, and the Sarcoma Analysis Working Group for The Cancer Genome Atlas (TCGA).

Dr. Hornick is the Editor-in-Chief of the American Journal of Surgical Pathology and the 5th series of the AFIP Atlases of Tumor and Non-tumor Pathology; the Editor of Practical Soft Tissue Pathology and Fletcher’s Diagnostic Histopathology of Tumors; an Associate Editor for Sternberg’s Diagnostic Surgical Pathology, Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, and Advances in Anatomic Pathology; and the Consulting Editor for Surgical Pathology Clinics. He has published over 500 original papers, review articles, and book chapters. Dr. Hornick received the 2012 Arthur Purdy Stout Society Annual Prize, the 2014 Jack Yardley Investigator Award from the Gastrointestinal Pathology Society, and the 2023 Mostofi Distinguished Service Award from the USCAP. He has 21-year-old twins and sings and plays keyboards for a rock band (the Tear Downs).

Dr. Magi-Galluzzi is the Division Director of Anatomic Pathology and Professor of Pathology at the University of Alabama at Birmingham. She received her MD at the University of Ancona, School of Medicine, Italy and her PhD in Oncologic Human Pathology at the University of Verona, Italy. She completed her residency in Anatomic and Clinical Pathology at Rush University Medical Center in Chicago (1997-1999) and Brigham & Women’s Hospital, Harvard Medical School in Boston (1999-2001), followed by a fellowship in Urologic Pathology at the Johns Hopkins University in Baltimore (2001-2003). She was on staff at the Cleveland Clinic from 2003 to 2018 and Director of Genitourinary pathology from 2004 to 2018.

Her clinical expertise is in the pathological diagnosis of genitourinary diseases, including prostate, bladder, testicular, adrenal and kidney malignancies. Her research interest focuses on prostate carcinogenesis and in the discovery and validation of tumor markers and genomic tests of value in furthering the goals of successful treatment and understanding of the pathogenesis of genitourinary disease. She is the author of numerous (~200) peer-reviewed publications, invited reviews and book chapters, as well as the editor of two books on genitourinary pathology. She has presented and lectured extensively at national and international meetings and has conducted national and international courses, workshops and slide seminars in urological pathology.

Dr. Nucci is a Professor of Pathology at Harvard Medical School, Vice Chair and Director of the Division Women’s and Perinatal Pathology, and Associate Director of the Pathology Residency Training Program in the Department of Pathology at the Brigham and Women’s Hospital in Boston, MA, USA. She also serves as a Consultant Pathologist for the Dana Farber/Harvard Cancer Center where she is an Associate Member of the Gynecologic Cancer and Sarcoma Programs. Dr. Nucci was born in Newark, NJ. She did her undergraduate training at Haverford College and medical training at the Johns Hopkins University School of Medicine in Baltimore, MD, and completed an AP residency as well as the Women’s and Perinatal Pathology Fellowship at the Brigham and Women’s Hospital. She has been on staff at the Brigham and Women’s Hospital since 1996. She is past president of the New England Society of Pathologists and serves on the editorial boards of The International Journal of Gynecologic Pathology, Human Pathology, and Advances in Anatomic Pathology. She is an active member of the United States and Canadian Academy of Pathology, where she served on the Education Committee (2011-2017), was Chair of the Subcommittee for Unique Live Course Offerings (2012-2017) and is a member of the Board of Directors (2016-). She is also Past-President of the Arthur Purdy Stout Society. She is the co-editor of three widely read major gynecologic pathology textbooks: Diagnostic Gynecologic and Obstetric Pathology edited by Drs. Crum, Nucci and Lee; Gynecologic Pathology. A Volume in the Series Foundations in Diagnostic Pathology edited by Drs. Nucci and Oliva; and Diagnostic Pathology Gynecological edited by Drs. Nucci and Oliva.

Dr. Billings completed his pathology residency at Indiana University School of Medicine in Indianapolis. Following residency, he completed fellowships in soft tissue pathology with Dr. Sharon Weiss at Emory University and dermatopathology with Dr. Antoinette Hood at Indiana University. Upon completion of his post-graduate studies, he joined the faculty at Indiana University School of Medicine, where he practiced for several years. In 2007 he joined the faculty at the Cleveland Clinic where he serves as a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, and was co-director of the dermatopathology section for over 15 years. He also staffs the soft tissue pathology service.

His research interests are in dermatopathology and soft tissue pathology, with a special emphasis on cutaneous soft tissue tumors. He has authored over 200 articles, 96 book chapters, and co-authored/edited 7 books.

He has a strong interest in education and gives numerous invited lectures and CME courses. He is on the editorial board of several journals, a peer reviewer for many more, and served on the Consensus Committee for the 4th edition of the WHO Classification of Skin Tumours.

For USCAP, he has given numerous lectures and served on the Education Committee and Board of Directors. He was also instrumental in developing Interactive microscopy at the Annual Meeting as well as the Palm Springs Interactive Center in his role as the first Chair of Interactive Microscopy for the Academy. For these and other achievements, he was awarded the 2021 F.K. Mostofi Distinguished Service Award.

Arie Perry, MD is a Professor of Pathology and Neurological Surgery at the University of California in San Francisco, where he serves as the Director of Neuropathology and the Neuropathology Fellowship program. He received his MD and residency training at UT Southwestern in Dallas, Texas, followed by surgical pathology, neuropathology, and molecular cytogenetics research fellowships at the Mayo Clinic in Rochester, MN, where he worked closely with his mentor, the late Dr. Bernd Scheithauer. His interests have focused mostly on classification, grading, and molecular characterization of both adult and pediatric brain tumors. He has authored over 650 publications and participated as an editor for the WHO 2016 and 2021 (5th ed.) CNS tumor classification updates, as well as an author in 10 of the 5th edition WHO blue books. He has also previously served as a chief editor for Brain Pathology (official journal of the International Society of Neuropathology), the Practical Surgical Neuropathology textbook (2 editions), and Greenfield’s Neuropathology (2 editions). Dr. Perry maintains an active consult service and is a frequently invited lecturer. He also enjoys creative modes of teaching making use of his longstanding passion for music. In this respect, he has been featured in several media stories for using “neuropathology songs” in medical education, including CD recordings and YouTube videos.

Dr. Anil Parwani is a Professor of Pathology and Biomedical Informatics at The Ohio State University. He serves as the Donald A. Senhauser Chair of the Department of Pathology and the Chief of Pathology Services for the Health System. His research is focused on diagnostic and prognostic markers in bladder, prostate, and renal cell carcinoma. Dr. Parwani has expertise in surgical pathology, and pathology informatics including biobanking, whole slide imaging, digital imaging, telepathology, image analysis, artificial intelligence, and lab automation. Dr Parwani has authored over four hundred peer-reviewed articles in major scientific journals and several books and book chapters. Dr. Parwani has served on the board of directors, education committee and abstract committee for USCAP and was the president of digital pathology association. He has also served on several committees including the AI Committee for the CAP. Dr. Parwani is the Editor-in-chief of Diagnostic Pathology and Co-editor of the Journal of Pathology Informatics.

Dr. Brat’s clinical expertise is in Surgical Neuropathology. He has authored two textbooks in Surgical Neuropathology and is a lead editor for the World Health Organization (WHO) Classification of Brain Tumors. Among achievements that he is most proud include original descriptions of chordoid glioma and extra-ventricular neurocytoma, as well as foundational investigations of pituicytoma, astroblastoma and melanocytic neoplasms of the CNS. His work with The Cancer Genome Atlas (TCGA) on diffuse gliomas ushered in a new molecular classification that is incorporated into WHO diagnoses and the subject of College of American Pathology (CAP) clinical practice guidelines. He continues to work closely with international leaders to optimize and integrate molecular diagnostic features into classification and grading criteria for these tumors. He has trained over a 120 residents and fellows in Surgical Neuropathology and participated in over 75 CME courses nationally and internationally. Dr. Brat also directs a basic and translational research lab that investigates mechanisms of glioma progression, including contributions from genetics and the tumor microenvironment. In the laboratory setting, he has trained and mentored over 70 students, residents and fellows and was awarded Mentor of the Year for post-doctoral training. He has written more than 350 peer-reviewed manuscripts and reviews.

Dr. Brat has served in leadership positions that oversee clinical practice, education and investigation in Oncology and Pathology, including the TCGA; CAP Neuropathology Committee (Chair) and Council on Scientific Affairs; Education Committee of the USCAP; the President and Executive Council, American Association of Neuropathologists; Board of Directors, Society of Neuro-oncology; and American Joint Commission on Cancer (AJCC) CNS Expert Panel (Chair). He is a member of the American Society for Clinical Investigation and the Association of American Physicians and serves as the Deputy Editor for the Journal of Clinical Investigation (JCI).

A native of Oregon, Dr. Chadburn graduated from Stanford Medical School, and did her pathology residency at the now New York Presbyterian Hospital – Weill Cornell Medicine (NYP-WC) with a hematopathology fellowship at Columbia Presbyterian. She subsequently was part of the hematopathology faculties at Columbia Presbyterian, Northwestern-Feinberg School of Medicine and Weill Cornell Medicine, focusing her career on lymphoid lesions, particularly those arising in the setting of immunosuppression. She has had many leadership roles in these institutions including Director of the Immunopathology Laboratory, Interim Co-director of Surgical Pathology, Program Director of the Residency and Hematopathology Fellowship programs, Director of the Immunohistochemistry Laboratory and Vice Chair of Quality and Clinical Services. She established her departmental mentoring program and has been an active member of the General Faculty Council.

Dr. Chadburn has been a member of USCAP since residency with many roles in the organization including as a member on the abstract review committee, chairman of the Stowell-Orbison Award Committee, member of the education committee and a USCAP mentor. She has given courses at the annual meeting and in Palm Springs and has organized the Hematopathology night sessions. She is currently on SULCO. She has been active in the Society of Hematopathology (membership and executive committees), American Society of Clinical Pathology (education committee and co-chair of the annual meeting) and the New York Pathological Society (president). She is on the Oregon State University College of Science Advisory Board and meets with undergraduates to foster their interest in medicine and is on the Castleman Disease Collaborative Network (CDCN) Scientific Advisory Board. She performs central review for Alliance and AIDS Malignancy Consortium clinical trials (lymphoma) and for CDCN (Castleman cases).

She has over 200 peer reviewed papers and several book chapters and has written for the WHO Classification of Tumours (hematopathology) in 2008, 2016, 2022 and (digestive tract) 2019. She is on editorial boards including Modern Pathology and Archives of Pathology and Laboratory Medicine. She received the Arthur Purdy Stout award. She has been listed as a Castle Connolly Top Doctor in New York City and Chicago and a Castle Connolly Exceptional Woman in Medicine.

Dr. Dry is Professor and Chair of Pathology and Laboratory Medicine at the University of California Los Angeles (UCLA) where she has been on the faculty since 2000. Dr. Dry, originally from the Hartford, Connecticut area, received her undergraduate degree from Yale University and her MD from the University of Connecticut. She completed her AP/CP training at the Brigham and Women’s Hospital and UCLA, and completed a soft tissue fellowship with Dr. Christopher Fletcher and a GI fellowship with Dr. Klaus Lewin at the Brigham and UCLA, respectively. Dr. Dry has been an active member of USCAP for over 20 years. She has served USCAP as an abstract reviewer, lead abstract reviewer, a moderator for platform sessions, a speaker for companion societies and evening specialty conferences, a faculty member at Interactive Microscopy Courses, a member of the Education Committee (EC) and she is currently a member of the EC subcommittee for unique live course offerings (SULCO). She is on the organizing committees for five new professional development educational offerings concerning EDI and women in pathology at the 2022 and 2023 USCAP annual meetings. She is a past Treasurer of the Arthur Purdy Stout Society and is a long-standing member of the Rodger Haggitt GI Pathology Society and the International Society of Bone and Soft Tissue Pathology. She has numerous publications, mainly on bone and soft tissue and biobanking topics, and is on the Editorial Board of Biopreservation and Biobanking. Dr. Dry continues to sign out on the UCLA bone and soft tissue and GI services, and she greatly enjoys these opportunities to interact with and teach trainees.

Dr. Faquin, who grew up in NC, now lives in Boston where he is Professor of Pathology at Harvard Medical School, Chief of Otolaryngologic Pathology at the Massachusetts Eye and Ear, Director of the MEE Frozen Section Laboratory, and a subspecialist in Head and Neck Pathology & Cytopathology at the Massachusetts General Hospital. He received his MD in 1993 from Harvard Medical School and obtained his PhD from Harvard studying erythrocyte cytoskeleton biochemistry. Dr. Faquin did his residency in Anatomic Pathology at the Brigham and Women’s Hospital in Boston (1993-1997) where he also completed fellowships in Women’s and Perinatal Pathology and Cytopathology. He joined the pathology faculty at the Massachusetts General Hospital in 1998. Dr. Faquin has been a member of USCAP for almost 30 years and an active contributor as co-director of multiple Head and Neck short courses & Interactive Microscopy courses at USCAP annual meetings, moderator of platform sessions, speaker at companion and evening specialty sessions, invited speaker at Interactive Microscopy courses at the Palm Springs Center, and faculty member in multiple USCAP Diagnostic Cytology Courses in the USA and abroad. Dr. Faquin has served on the USCAP Education Committee, Abstract Research Award Committee, DEI subcommittee, SULCO subcommittee, USCAP Mentoring Academy, and Chair of the Castleman Award Committee. He has also delivered numerous lectures at national and international meetings of the ASC, CAP, ECC, IAP, and ASCP, and served on the ASC Executive Board.

Dr. Faquin is recognized for his contributions to the study of thyroid, salivary gland, and HPV-related cancers of the head and neck. He has over 400 publications, and co-authored several books on head and neck cytohistology, salivary gland, and thyroid cytopathology. Dr. Faquin has been an Editorial Board member for 9 pathology journals, and is currently the Editor-in-Chief for Cancer Cytopathology. He is an author of the upcoming ARP Fascicle for Upper Aerodigestive Tract Tumors, co-author of the Bethesda System for Reporting Thyroid Cytopathology, co-chair of the CAP Guideline Committee for HPV testing in the head and neck, contributor to the 5th Edition of the WHO Classification of Head and Neck Tumours, and co-editor of the Milan System for Reporting Salivary Gland Cytopathology. In his free time, Dr. Faquin is an avid gardener and has been a bonsai artist for 53 years with a collection of over 60 bonsai pine trees.

Dr. Graham, originally from Barbados, is a Professor of Laboratory Medicine and Pathology at the Mayo Clinic in Rochester Minnesota. He received his medical degree from the University of the West Indies in Jamaica in 2006 before completing residency and fellowships, at Mayo Clinic, in Molecular Genetic Pathology, Surgical Pathology and GI/Liver Pathology. At the Clinic, Dr. Graham serves as the Executive Vice Chair of Academics and People in the Division of Anatomic Pathology, as well as the Associate Vice Chair of Test Development and the Lead Consultant for Business Development in the Department of Lab Medicine and Pathology. He is a member of the institution’s Academic Appointments and Promotions Committee and the Mayo Clinic Cancer Center Hepatobiliary Disease Group Executive Team. Dr. Graham is an academic GI/Liver pathologist whose scholarly interests are at the intersection of GI/Liver pathology and molecular genetics. He has authored over 195 peer-reviewed publications along with 27 book chapters and has been a contributor to the WHO Classification of Tumors of the Digestive System and the WHO Classification of Pediatric Tumors. He serves on the Editorial Board of Modern Pathology, is an Associate Editor for Journal of Molecular Diagnostics and reviews for over 2 dozen biomedical journals. He has been invited to give over 100 presentations at academic meetings and visiting professorships at national and international venues. In 2023, he was awarded the Arthur Purdy Stout Society Pathology Annual Prize Dr. Graham has served the USCAP in several administrative capacities including Abstract Review Committee, Lead Reviewer for the Liver Section, Focus Group on Diversity Equity and Inclusion (2018), the USCAP Membership Committee (2018-2021), Foundation Committee (current) and the CME Subcommittee (current) as well as educational roles such as moderator and course director. Dr. Graham lives in Rochester, Minnesota with his wife and 3 children. He is an avid soccer fan and loves growing orchids.

Dr. Hui is Professor in the Department of Pathology at Yale School of Medicine. He obtained his medical degree from Xi’an Jiaotong University in China in 1984 and PhD from SUNY at Buffalo in 1994. He received combined anatomic and clinical pathology residency training at Yale-New Haven Hospital in 2000, followed by oncological pathology fellowship training at MSKCC in 2001. Dr. Hui is a board-certified surgical pathologist with clinical expertise in gynecologic pathology and molecular genetic pathology. He is Director of Gynecologic Pathology, Clinical Director of Molecular Diagnostics Laboratory, and Director of Center for the Precision Medicine of Trophoblastic Disease at Yale School of Medicine. He has authored over 280 publications and four gynecological pathology textbooks. Dr. Hui serves on editorial boards of International Journal of Gynecological Pathology, Modern Pathology, Human Pathology and Virchows Archiv. Dr. Hui has played a significant role as a consensus/expert editorial board member for the 4th, 5th, and the ongoing 6th editions of the WHO Tumor Classifications of Female Reproductive Organs. He serves on the Board of Directors of the International Society of Gynecological Pathologists (ISGyP) and is currently the President-Elect of the society, reflecting his leadership and expertise in the field of gynecological pathology.

Dr. Hui has dedicated many years to serving the United States and Canadian Academy of Pathology (USCAP) in various capacities. His roles have included being a USCAP ambassador, abstract reviewer, and faculty member for USCAP specialty courses in 2012. He was course director of USCAP short courses in 2013, 2014, 2015, and more recently in 2022 and 2023. At the USCAP Interactive Center in Palm Springs, he contributed as faculty for the interactive microscopy course on intraoperative consultation in 2019 and served as program director for multiple interactive microscopy courses on gynecological pathology in 2017, 2018, and 2019. He also led co-branded interactive microscopy courses in collaboration with the International Society of Gynecological Pathologists (ISGyP) in 2021, 2022, and 2024. Dr. Hui’s unwavering commitment to the Academy’s mission is evident in his efforts to foster academic collaborations, drive innovations, and enhance the clinical practice of pathology with a global impact.

Dr. Sanders is Professor of Pathology, Microbiology and Immunology and expert breast pathologist at Vanderbilt University Medical Center where she is also Director of Breast Pathology. She joined the Vanderbilt Surgical Pathology faculty and Breast Consultation Service faculty in 2001, after training in breast pathology under Dr. David Page. Her expertise spans the full spectrum of benign proliferative lesions, distinction of atypical hyperplasia from carcinoma in situ, spindle cell and papillary lesions, metaplastic carcinoma and other unusual subtypes of breast carcinoma. She is a frequent presenter at national meetings and society-sponsored courses. Dr. Sanders has authored 2 breast pathology books and numerous book chapters on a variety of breast pathology topics. Throughout her career, Dr. Sanders has also been highly active in translational breast cancer research and clinical trial pathology. She serves as the lead breast pathologist for the Vanderbilt Ingram Cancer Center breast cancer research program and tissue core director for the Vanderbilt NCI-sponsored Breast SPORE grant since 2005. Her research interests include genomic markers of endocrine resistance in estrogen receptor positive breast cancer, tumor immunology, genomic subcategorization of TNBC, markers predictive of response to neoadjuvant therapy (NAT) and genomic characterization of residual disease following NAT. Dr. Sanders has also provided histopathologic guidance for spectroscopy studies seeking to evaluate margins intraoperatively and imaging studies to identify radiologic correlates of response to neoadjuvant therapies. She has co-authored over 90 papers in breast pathology and cancer research.

Dr. Weinberg received her undergraduate degree from the University of Chicago followed by medical degree from Vanderbilt School of Medicine. She participated in Howard Hughes medical student fellowship at UCLA and subsequently did her residency training in anatomic pathology and a surgical pathology and hematopathology fellowships at Stanford University School of Medicine. Dr. Weinberg started her academic career at Boston Children’s Hospital and Brigham and Women’s hospital and recently moved to UT Southwestern Medical Center, where she serves as an associate professor of pathology, director of fellowship education and hematology laboratory. Dr. Weinberg has served on numerous education committees including USCAP, Society of Hematopathology, and International Clinical Cytometry Society and is currently a member of the executive committee of the Society of Hematopathology and board member of International Society for Laboratory Hematology. She has co-organized a national Society of hematopathology workshop on “Molecular Genetics of Hematopoietic Neoplasms” in 2017 that was attended by over 400 hematopathologists. She has taught and directed numerous education courses including initiating a successful Harvard CME course ‘Current concepts in hematopathology’ in the Boston area as well as held numerous hematopathology courses at USCAP, CAP and ASCP conferences. She has attended the USCAP annual meetings for the past 15 years and has been an abstract reviewer, platform session moderator, companion society and evening specialty session speaker and recently directed an interactive microscopy course in Palm Springs. On a clinical research side, she has a long-standing interest in acute leukemias and myeloid neoplasms and published over 90 papers in well-regarded journals including Modern Pathology, American Journal of Hematology, Blood and Blood Advances and presented her work at numerous national conferences including USCAP, ASH and ASCP and CAP. She has served on editorial boards of several well-known journals and co-authored numerous chapters and edited a book on flow cytometry.

Dr. Westerhoff is a full professor and the Assistant Chair of Wellness and Culture at the University of Michigan. Originally from Seoul, South Korea, she completed her residency and gastrointestinal and liver fellowship at the University of Chicago. She began her academic career at the University of Washington in 2011, where she was recognized twice as Faculty Educator of the Year. She has been a member of the University of Michigan Pathology Department since 2017. Dr. Westerhoff has attended every USCAP meeting since her first year of residency. She served as Lead Reviewer of the Liver Pathology Category as part of the USCAP Abstract Review Committee. She was also a member of the USCAP Publications Committee and was elected to the USCAP Education Committee in 2019. Dr. Westerhoff has presented in multiple USCAP offerings, including at the USCAP Evening Specialty conferences for both Gastrointestinal and Liver subspecialties. She has also taught USCAP Liver Pathology Short Courses alongside Drs. John Hart and Lei Zhao. In addition, Dr. Westerhoff has participated as a faculty member of multiple USCAP Interactive Microscopy Courses. Dr. Westerhoff has experience serving on the executive boards of multiple companion societies. She is the Past-President of the Rodger Haggitt GI Pathology Society (GIPS) and has previously organized the content and speakers for the 2019 USCAP Companion Society meeting for GIPS. Moreover, she has also organized GIPS symposia at ASCP, CAP, European Congress of Pathology, and Digestive Disease Week. She served as Treasurer of the Arthur Purdy Stout Society of Surgical Pathologists from 2019-2023. She is a member of the Korean Pathologists Association of North America, the Laennec Liver Society, and has participated as a Journal Club writer for the Hans Popper Hepatopathology Society. Dr. Westerhoff has given numerous lectures nationally and internationally to multidisciplinary audiences regarding both liver and gastrointestinal topics. She has authored over 100 peer reviewed publications, the Hepatobiliary and Pancreas textbook of the Elsevier Diagnostic Pathology series, and 17 book chapters. She lives in Ann Arbor, Michigan, with her husband and three children. She enjoys promoting wellness in her department for faculty, staff, and trainees.